PL3525783T3 - Leczenie raka dróg żółciowych fotochemiczną internalizacją gemcytabiny indukowaną TPCS-2A - Google Patents
Leczenie raka dróg żółciowych fotochemiczną internalizacją gemcytabiny indukowaną TPCS-2AInfo
- Publication number
- PL3525783T3 PL3525783T3 PL17791004T PL17791004T PL3525783T3 PL 3525783 T3 PL3525783 T3 PL 3525783T3 PL 17791004 T PL17791004 T PL 17791004T PL 17791004 T PL17791004 T PL 17791004T PL 3525783 T3 PL3525783 T3 PL 3525783T3
- Authority
- PL
- Poland
- Prior art keywords
- tpcs
- cholangiocarcinoma
- gemcitabine
- treatment
- photochemical internalisation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1617526.7A GB201617526D0 (en) | 2016-10-14 | 2016-10-14 | Method |
GBGB1704719.2A GB201704719D0 (en) | 2017-03-24 | 2017-03-24 | Method |
EP17791004.9A EP3525783B1 (en) | 2016-10-14 | 2017-10-13 | Treatment of cholangiocarcinoma with tpcs-2a induced photochemical internalisation of gemcitabine |
PCT/EP2017/076257 WO2018069536A1 (en) | 2016-10-14 | 2017-10-13 | Treatment of cholangiocarcinoma with tpcs-2a induced photochemical internalisation of gemcitabine |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3525783T3 true PL3525783T3 (pl) | 2021-04-19 |
Family
ID=60186250
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL17791004T PL3525783T3 (pl) | 2016-10-14 | 2017-10-13 | Leczenie raka dróg żółciowych fotochemiczną internalizacją gemcytabiny indukowaną TPCS-2A |
Country Status (13)
Country | Link |
---|---|
US (1) | US20200338044A1 (pl) |
EP (1) | EP3525783B1 (pl) |
JP (1) | JP2019530718A (pl) |
KR (1) | KR20190068573A (pl) |
CN (1) | CN110022874A (pl) |
AU (1) | AU2017342086A1 (pl) |
CA (1) | CA3040344A1 (pl) |
DK (1) | DK3525783T3 (pl) |
ES (1) | ES2841941T3 (pl) |
PL (1) | PL3525783T3 (pl) |
RU (1) | RU2019109682A (pl) |
SG (1) | SG11201903057XA (pl) |
WO (1) | WO2018069536A1 (pl) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201913121D0 (en) * | 2019-09-11 | 2019-10-23 | Seald As | Compositions and methods for treatment of cholangiocarcinoma |
GB201913124D0 (en) * | 2019-09-11 | 2019-10-23 | Seald As | Compositions and methods for treatment of cholangiocarcinoma |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO180167C (no) | 1994-09-08 | 1997-02-26 | Photocure As | Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol |
GB9905911D0 (en) | 1999-03-15 | 1999-05-05 | Photocure As | Method |
KR100980153B1 (ko) | 2000-11-29 | 2010-09-03 | 피씨아이 바이오테크 에이에스 | 사이토졸 내로의 분자 전달을 위한 광화학적 내부이행 |
GB0121023D0 (en) * | 2001-08-30 | 2001-10-24 | Norwegian Radium Hospital Res | Compound |
GB0914286D0 (en) * | 2009-08-14 | 2009-09-30 | Pci Biotech As | Method |
GB0914287D0 (en) | 2009-08-14 | 2009-09-30 | Pci Biotech As | Compositions |
-
2017
- 2017-10-13 DK DK17791004.9T patent/DK3525783T3/da active
- 2017-10-13 EP EP17791004.9A patent/EP3525783B1/en active Active
- 2017-10-13 KR KR1020197013250A patent/KR20190068573A/ko not_active Application Discontinuation
- 2017-10-13 SG SG11201903057XA patent/SG11201903057XA/en unknown
- 2017-10-13 US US16/341,186 patent/US20200338044A1/en not_active Abandoned
- 2017-10-13 WO PCT/EP2017/076257 patent/WO2018069536A1/en unknown
- 2017-10-13 RU RU2019109682A patent/RU2019109682A/ru not_active Application Discontinuation
- 2017-10-13 PL PL17791004T patent/PL3525783T3/pl unknown
- 2017-10-13 CA CA3040344A patent/CA3040344A1/en not_active Abandoned
- 2017-10-13 CN CN201780073846.XA patent/CN110022874A/zh active Pending
- 2017-10-13 ES ES17791004T patent/ES2841941T3/es active Active
- 2017-10-13 AU AU2017342086A patent/AU2017342086A1/en not_active Abandoned
- 2017-10-13 JP JP2019519974A patent/JP2019530718A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
RU2019109682A3 (pl) | 2021-02-15 |
DK3525783T3 (da) | 2021-01-18 |
CN110022874A (zh) | 2019-07-16 |
EP3525783A1 (en) | 2019-08-21 |
RU2019109682A (ru) | 2020-11-16 |
JP2019530718A (ja) | 2019-10-24 |
CA3040344A1 (en) | 2018-04-19 |
US20200338044A1 (en) | 2020-10-29 |
AU2017342086A1 (en) | 2019-05-09 |
KR20190068573A (ko) | 2019-06-18 |
EP3525783B1 (en) | 2020-12-16 |
ES2841941T3 (es) | 2021-07-12 |
SG11201903057XA (en) | 2019-05-30 |
WO2018069536A1 (en) | 2018-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL252839A0 (en) | Treatment of boils | |
IL261959A (en) | Cancer treatment with tg02 | |
HK1248552A1 (zh) | 使用川地匹坦的治療方法 | |
IL268694A (en) | Treatment of schizophrenia | |
IL247354B (en) | Treatment of conditions related to excess insulin in the blood | |
ZA201706257B (en) | Treatment of wood | |
GB201608885D0 (en) | Treatment | |
HK1252692A1 (zh) | 治療或者預防蛋白質構象病的方法 | |
HK1259347A1 (zh) | 治療結腸炎的方法 | |
IL264451B1 (en) | A combination of abt-199 and achmetalstat for the treatment of aml | |
HK1249866A1 (zh) | 用他塞利昔布進行治療的方法 | |
PL3525783T3 (pl) | Leczenie raka dróg żółciowych fotochemiczną internalizacją gemcytabiny indukowaną TPCS-2A | |
GB201402909D0 (en) | Treating infection | |
PL3220952T3 (pl) | Sposób leczenia lub zapobiegania udarowi | |
SG11201607608UA (en) | Enzymatic treatment of cellulosic textile | |
PL3638370T3 (pl) | Leczenie migreny acetyloleucyną | |
HK1252385A1 (zh) | 錫生藤提取物治療登革熱的用途 | |
GB201412010D0 (en) | Treatment of hypertransaminasemia | |
HK1244210A1 (zh) | 人參皂苷m1用於預防或治療痛風的用途 | |
GB201512139D0 (en) | Methods of treatment | |
IL281595A (en) | Cholangiocarcinoma treatment | |
HK1243653A1 (zh) | S-亞硝基硫醇的滅菌方法 | |
GB201617107D0 (en) | Treatment | |
GB201612260D0 (en) | Treatment | |
GB201612193D0 (en) | Treatment |